Ten-day clock ticking on SBIR reauthorization

The 2026 SBIR/STTR reauthorization bill (S. 3971, the Small Business Innovation and Economic Security Act) has cleared Congress and is now awaiting final action by the President. The Senate passed the bill by unanimous consent on March 3, 2026. The House subsequently approved the Senate-passed measure on March 17, 2026, by a vote of 345–41. Because the House adopted the Senate version without amendment, the bill moved straight to enrollment, where the final official copy is prepared for signature before being sent to the White House.

Compromise on SBIR reauthorization released; Congressional votes expected soon

It has been five long, dark months for the nation’s small innovation-focused businesses and the regional innovation systems that rely on them for their strongest startups and future leaders, but a ray of light appeared Wednesday afternoon as a compromise was announced on the stalled reauthorization of the federal SBIR/STTR programs. And, if passed as written, we won’t have to go through this again until September 2031, which shifts future debate until an off-election year.

It has been five long, dark months for the nation’s small innovation-focused businesses and the regional innovation systems that rely on them for their strongest startups and future leaders, but a ray of light appeared Wednesday afternoon as a compromise was announced on the stalled reauthorization of the federal SBIR/STTR programs. And, if passed as written, we won’t have to go through this again until September 2031, which shifts future debate until an off-election year.

Recent Research: Are SBIR-funded inventions more likely to make it to market?

Commercializing patented inventions is a common goal of innovation policy, as it drives company revenues and regional economic growth. However, tracking the commercialization of inventions stemming from R&D is challenging. While programs like the Small Business Innovation Research (SBIR) program are explicitly designed to encourage commercialization, most evaluation tools rely on approaches that may be anecdotal or incomplete, such as surveys, case studies, or patent counts.

Commercializing patented inventions is a common goal of innovation policy, as it drives company revenues and regional economic growth. However, tracking the commercialization of inventions stemming from R&D is challenging. While programs like the Small Business Innovation Research (SBIR) program are explicitly designed to encourage commercialization, most evaluation tools rely on approaches that may be anecdotal or incomplete, such as surveys, case studies, or patent counts. A working paper by Carlo Bottai, Gaétan de Rassenfosse, and Emilio Raiteri proposes a new web-based methodology for detecting commercialization, offering a potentially more objective, real-time way to gauge the return on public innovation investments. It might prove a useful tool for state TBED programs that support R&D grants, research centers, and university-industry research collaboration.

SBIR/STTR reauthorization bill includes many big changes

A two-page proposal for a $40,000 Phase IA award? Phase II performance ratios required for companies receiving 10 and 25 Phase I awards over their lifetime? Halving the budget for STTR and shrinking university partner share? Creating a 0.25% carve-out of DOD SBIR funds for phase III awards up to $30M each? Limiting all federal technical assistance and outreach to 25 states with the fewest SBIR/STTR awards? Stronger, broader, tougher foreign risk requirements for the companies and agency due diligence?